MigreLief has been highly effective in my practice of patients with difficult migraine headaches
I run a headache clinic and suggest your products frequently. Having samples to hand the patient will help a lot. Thanks.
I’m a nurse practitioner and recommend MigreLief every day.
Where to Find Us
Available online and at independent pharmacies nationwide
If MigreLief is not available at a local independent pharmacy, your patients can request that it be ordered through one of our listed pharma distributors, and receive it within approximately 24-48 hours.
Store & Pharmacy Locator
- Available at independent pharmacies, the Vitamin Shoppe, Meijers, Amazon and in our online store at MigreLief.com
- Available for Healthcare Professionals – Resale
For healthcare professionals who would like to stock MigreLief or other Akeso Condition Specific products in their clinic or practice,
please read about our Chief Scientific Officer, Curt Hendrix (below), and complete our Wholesale Application.
Akeso Health Sciences LLC
Formed in 1992, Akeso Health Sciences is a natural medicine/dietary supplement company with two lines of products: MigreLief and Condition Specific. Two international patents were granted covering our uniquely effective MigreLief formulation, and for more than two decades, MigreLief has provided effective nutritional support to hundreds of thousands of migraine sufferers.
Curt Hendrix, M.S. C.C.N. C.N.S, is the Chief Scientific Officer for both Akeso Health Sciences and Concourse Health Sciences, a pharmaceutical company developing prescription drugs from natural compounds. Mr. Hendrix has dedicated his life to the research and development of innovative natural medicines, studying the profound link between human biology and the chemistry found in nature, as well as why diseases and health conditions occur, progress, reverse, or never occur at all. He has been named as the Principal Investigator in multiple National Institutes of Health (NIH) governmental grants studying the benefits of natural medicines on disease.